| JYHZ2100558 | 沙格列汀二甲双胍缓释片（Ⅱ） | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | License Renew | 2021-06-09 | | | | | view |
| JYHZ2100555 | 沙格列汀二甲双胍缓释片（Ⅱ） | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | License Renew | 2021-06-09 | | | | | view |
| JYHB2300377 | 沙格列汀二甲双胍缓释片（Ⅱ） | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2023-07-08 | | | | | view |
| JYHB2300374 | 沙格列汀二甲双胍缓释片（Ⅱ） | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2023-07-08 | | | | | view |
| JXHS1300100 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Import Drug Application | 2013-12-05 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2017-05-22 | view |
| CXHL1401435 | 沙格列汀二甲双胍缓释片(Ⅱ) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs(3.2) | New Drug Application | 2014-11-17 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2016-03-24 | view |
| JYHF1700057 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2017-06-22 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Certificate Issued | 2017-08-01 | view |
| JYHB1700837 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2017-06-21 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Certificate Issued | 2018-06-04 | view |
| JYHB1700742 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2017-06-05 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Certificate Issued | 2017-07-17 | view |
| JYHB2001835 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2020-09-21 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Filed | 2020-10-12 | view |
| JYHB1801508 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2019-01-28 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-09-29 | view |
| JYHB1801511 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2019-01-28 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-09-29 | view |
| JYHB1801264 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2018-10-24 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2018-10-25 | view |
| JYHB2001400 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2020-08-21 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2020-09-02 | view |
| JYHB1801263 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2018-10-24 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2018-10-25 | view |
